2012 CABA Symposium Features High Level Officials from China

By David Li, bostonese.com

The 2012 CABA (Chinese American BioMedical Association) Investment, Innovation & Entrepreneurship Symposium will be held on Oct 20, from noon to 9:00 PM. With high level officials from China as keynote speakers, this year’s symposium provides an excellent opportunity to learn about investment and career opportunities in China. It also provides a wonderful networking opportunity for people working in the bio-medical field, locally and internationally.

Dr. Peng Wang introduces BioLake at last year’s CABA Symposium.

The theme of 2012 CABA Investment, Innovation & Entrepreneurship Symposium will be on “Opportunities for Biopharmaceutical Investors and Entrepreneurs”. This year’s symposium will provide a unique forum where industry executives, entrepreneurs, scientists, academics, government policy makers, and professionals from financial and investment communities engage in an in-depth discussion on business, investment and start-up opportunities at a time of increased pharma consolidation and externalization.

The highlights for this year’s discussion

  • Drug R&D and US-China biomedical exchange
  • Government’s impacts on biotech/pharmaceutical industries
  • Consolidation and Externalization
  • Successful biotech entrepreneur stories
  • Business and startup opportunities

Tentative Speakers

  • Weizhong Wang, PhD, Vice Minister, Minister of Science & Technology of China
  • Shijin Liu, PhD, Vice Minister, Development Research  Center, State Council of China
  • Anne Altmeyer, VP, Business Development – Novartis Oncology
  • Anthony P. Colasin, Sr. Director, Business Development – Ironwood Pharmaceuticals, Inc.
  • Hui Cai, PhD, MBA, WuXi AppTec Inc. VP, Corporate Alliances

Panel Discussion: BioPharm’s Innovation & Entrepreneurship

  • Jinbo Lee, PhD, Chief Scientific Officer, Scilligence: Software for Life Sciences
  • Karl Qin, President and founder of Biopharma Vision LLC
  • Ming Tong, MD, MBE, Senior Medical Consultant & Director, Beijing Biopharma International
  • Chaoyang Dai, VP, Acebright

Panel Discussion: 2012 Global Outsourcing Strategies & Trends

  • Bing Yu, PhD, GLSyntech, General Manager
  • Charles Huang, Sundia MediTech Company, VP of Global Business Development
  • George Shi, Ph.D., CSO, Anichem, Inc
  • Hui Li, Ph.D., BioDuro/PPD, Head of Business Development
  • Lixin Shen, PhD, CEO, Wuxi Howfond Biopharma Co., Ltd.
  • YaJun Xu, PhD, ChemPartner Co. USA, Sr. VP, Corporate Development

BioLake Investment Opportunities.

Admission:  On-site registration. CABA members: FREE; Non-members: $20.

CABA membership registration is available on-site and online
Networking reception: A networking reception (wine/beer & Hors d’Oeuvres, 5:30 PM–6:15 PM) will follow the afternoon sessions.

Parking Direction: Please enter the Double Tree Suites parking garage from Storrow Drive. Parking is free. The address of the hotel is: 400 Soldiers Field Road Boston, MA 02134.